Splenomegaly with Portal Vein Dilatation: Etiology, Evaluation, and Management

Overview

• Goldman-Cecil Medicine, p. 3883
• Current Surgical Therapy 14e, p. 455

CT Appearance

Part 1: Etiology

Classification by Site of Obstruction

• Current Surgical Therapy 14e, p. 455
• Goldman-Cecil Medicine, p. 4023

Additional Causes of Splenomegaly (Grouped by Mechanism)

• Malaria, leishmaniasis (kala-azar - produces the largest spleens globally)
• Hereditary spherocytosis, early sickle cell anemia, thalassemia
• Autoimmune hemolytic anemia, autoimmune neutropenia, ITP

• Cirrhosis (all etiologies)
• Portal vein thrombosis, splenic vein thrombosis
• Cardiac failure (right-sided), constrictive pericarditis
• Budd-Chiari syndrome

• Malignant: leukemias (CML produces the largest spleens in the malignant category), lymphomas, hairy cell leukemia, myelofibrosis, metastatic tumors
• Benign: Gaucher's disease, Niemann-Pick disease, amyloidosis, sarcoidosis

• Felty's syndrome (RA + splenomegaly + neutropenia)
• SLE, systemic mastocytosis
• Harrison's Principles of Internal Medicine 22e, Table 70-2

The Hepatic Venous Pressure Gradient (HVPG) Localizes the Level

• Goldman-Cecil Medicine, p. 4023

Part 2: Evaluation

History and Physical Examination

• Symptoms: Left upper quadrant heaviness or pain, early satiety (stomach compression), symptoms of hypersplenism (fatigue from anemia, bleeding from thrombocytopenia)
• Risk factors: Alcohol use, viral hepatitis exposure (HBV/HCV), travel to malaria/schistosomiasis-endemic areas, hypercoagulable state (for portal vein thrombosis), cardiac disease
• Physical exam: Spleen is palpable only when enlarged ~3x; record centimeters below the costal margin. Look for stigmata of liver disease (jaundice, palmar erythema, spider angiomata, caput medusae, ascites), elevated JVP (cardiac cause)

• Harrison's Principles of Internal Medicine 22e, p. 522-524

Laboratory Evaluation

• CBC with differential: cytopenias suggest hypersplenism (↓Hgb, ↓WBC, ↓platelets)
• LFTs, albumin, bilirubin, INR: assess hepatic synthetic function and degree of liver disease
• Peripheral blood smear: spherocytes (hereditary spherocytosis, hemolysis), teardrop cells (myelofibrosis), blasts (leukemia)
• Reticulocyte count

• Viral hepatitis panel (HBsAg, anti-HCV)
• ANA, anti-smooth muscle Ab, AMA (autoimmune liver disease)
• Iron studies, ferritin (hemochromatosis)
• Ceruloplasmin, slit-lamp exam (Wilson's disease in young patients)
• Serum protein electrophoresis (amyloid, myeloma)
• JAK2 mutation (myeloproliferative neoplasm, Budd-Chiari)
• Hypercoagulability workup (Factor V Leiden, prothrombin mutation, antiphospholipid Ab) if portal vein thrombosis suspected
• Thick blood film for malaria (if travel history)
• Serology for leishmaniasis in endemic areas

Imaging

• Measures spleen size, portal vein diameter (>13 mm = dilated), flow velocity and direction (hepatofugal flow = severe portal hypertension), detects ascites, liver echogenicity
• Assess for portal vein thrombosis, cavernous transformation, collaterals

• Best overall assessment: liver morphology (cirrhotic vs. normal), spleen size, portal vein patency, collateral vessels (varices, recanalized umbilical vein), splenic or hepatic lesions
• Contrast-enhanced CT can also show arteriovenous fistulae

• Superior soft-tissue characterization; useful for infiltrative diseases (Gaucher's, amyloid), biliary pathology, hepatic venous anatomy (Budd-Chiari)

• Non-invasive assessment of liver fibrosis; correlates with HVPG
• A liver stiffness >20-25 kPa is highly predictive of clinically significant portal hypertension
• Note: overestimates stiffness in postprandial state, hepatic inflammation, cholestasis, and right heart failure
• Sleisenger & Fordtran's Gastrointestinal and Liver Disease, p. 3338
• Goldman-Cecil Medicine, p. 4023

• Gold standard for quantifying portal pressure; performed by hepatic vein catheterization
• Direct portal vein catheterization is rarely needed and carries risks
• Guides prognosis and monitors treatment response

• Detects and grades esophageal/gastric varices
• Varices graded: small (straight, minimally elevated), medium (<1/3 lumen), large (>1/3 lumen)
• White nipple sign, adherent clot, or active bleeding from a varix confirms variceal hemorrhage

Part 3: Management

Treat the Underlying Cause

Reduce Portal Pressure - Medical Therapy

• Propranolol or nadolol: reduce portal pressure by ~20%; first-line for primary and secondary prophylaxis of variceal bleeding
• Carvedilol (alpha1 + non-selective beta): superior portal pressure reduction; increasingly preferred
• Target: reduce HVPG to <12 mmHg or by >20% from baseline; or heart rate to 55-60 bpm

• Terlipressin or octreotide/somatostatin: acute variceal hemorrhage; reduce splanchnic blood flow

Endoscopic Management

• Endoscopic variceal ligation (EVL): primary prophylaxis (large varices with high-risk features), acute bleeding, secondary prophylaxis
• Endoscopic sclerotherapy: less favored due to higher complication rate vs. EVL
• Combined EVL + NSBBs: standard for secondary prophylaxis

Interventional Radiology - TIPS

• Creates a shunt between portal and hepatic veins through liver parenchyma
• Rapidly reduces portal pressure
• Indications: refractory ascites, refractory variceal bleeding, Budd-Chiari, hepatic hydrothorax
• Limitations: risk of hepatic encephalopathy (reduced hepatic perfusion); contraindicated in severe hepatic encephalopathy, right heart failure, polycystic liver disease
• TIPS has largely replaced surgical shunts in current practice
• Current Surgical Therapy 14e, p. 455-456

Surgical Shunts (Selective Indication)

• Distal splenorenal shunt (Warren shunt): selective decompression while preserving hepatic portal perfusion; lower encephalopathy rate
• Portocaval shunt: non-selective; high risk of encephalopathy
• Mesocaval shunt: bridges portal to IVC via graft

Management of Hypersplenism

• Splenomegaly with cytopenia (hypersplenism): usually managed conservatively
• Splenectomy indications: symptomatic massive splenomegaly, refractory cytopenias, splenic rupture, staging (Hodgkin's lymphoma in select cases), hairy cell leukemia, hereditary spherocytosis
• Pre-splenectomy vaccines (mandatory): pneumococcal, meningococcal, Hib - given at least 2 weeks before elective splenectomy
• Splenic artery embolization: partial embolization as alternative to splenectomy in high-surgical-risk patients
• Harrison's Principles of Internal Medicine 22e, p. 524
• Bailey and Love's Short Practice of Surgery 28e, p. 3857-3860

Liver Transplantation

• Definitive treatment for end-stage liver disease with portal hypertension
• Cures both the liver dysfunction and portal hypertension
• Gold standard for cirrhotic portal hypertension when patient is a suitable candidate
• Non-cirrhotic etiologies (e.g., portal vein thrombosis, schistosomiasis) are generally not indications for transplant

Management of Ascites

• Sodium restriction (<2g/day)
• Spironolactone ± furosemide (aldosterone antagonist is primary)
• Large-volume paracentesis + albumin infusion for tense ascites
• TIPS for refractory ascites

Acute Variceal Hemorrhage (Emergency Management)

1. Airway protection, IV access, transfuse to Hgb ~7-8 g/dL
2. Vasoactive agents: octreotide or terlipressin (started immediately, before endoscopy)
3. Antibiotics: short-course norfloxacin or ceftriaxone (reduces bacterial translocation, improves survival)
4. Urgent EGD within 12 hours: EVL is treatment of choice
5. TIPS if bleeding uncontrolled or early rebleeding
6. Balloon tamponade (Sengstaken-Blakemore tube): bridge to definitive therapy

Summary Algorithm

Splenomegaly + Portal Vein Dilatation on Imaging
           ↓
  Assess for portal hypertension
           ↓
  Doppler US: portal vein >13mm, hepatofugal flow?
           ↓
  Classify: Prehepatic / Intrahepatic / Posthepatic
           ↓
  LFTs, CBC, viral hepatitis, autoimmune, metabolic workup
           ↓
  Liver stiffness measurement (FibroScan/elastography)
           ↓
  EGD: screen for varices
           ↓
  Treat underlying cause + Portal pressure reduction (NSBBs)
           ↓
  Endoscopic prophylaxis (EVL) for high-risk varices
           ↓
  TIPS or surgical shunts for refractory cases
           ↓
  Liver transplant evaluation for end-stage disease

Recent Evidence (2024-2026)

• Splenic transient elastography for portal hypertension (PMID: 40900859) - A 2025 review supports splenic stiffness measurement (via SWE or ARFI) as a promising non-invasive marker for clinically significant portal hypertension, complementing liver stiffness
• Multiparametric ultrasound for splenic pathology (PMID: 39417855) - A 2025 review highlights contrast-enhanced US and elastography as key additions to B-mode US for characterizing splenomegaly
• TIPS for ectopic variceal bleeding (PMID: 38935315) - 2024 systematic review confirms TIPS as an effective rescue therapy for ectopic varices refractory to endoscopy

• Harrison's Principles of Internal Medicine 22e (2025), Ch. 70
• Goldman-Cecil Medicine, Ch. 154 (Splenomegaly), Ch. 144 (Portal Hypertension)
• Current Surgical Therapy 14e, "Portal Hypertension: Role of Shunting Procedures"
• Sleisenger & Fordtran's Gastrointestinal and Liver Disease, Ch. 93
• Bailey & Love's Short Practice of Surgery 28e, Ch. 70